SX Symptom Management (Poster)

Thursday, May 30, 2013: 7:00 PM-8:30 PM
Consensus Conference: Comprehensive Management of Complex Symptoms in MS
Susan E. Bennett, PT, DPT, EdD, NCS, MSCS, University of Buffalo, SUNY; Francois Bethoux, MD, Cleveland Clinic Mellen Center

Promoting Confidence and Self Management Skills In Those Newly Diagnosed With MS
Therese V Burke, RN CNC, Institute for Immunology and Allergy Research

Post-Void Residual Measurements in MS Patients Without Urinary Symptoms
Claudia Chaves, MD, Lahey Clinic; Rik Ganguly, BS, Lahey Clinic; Ann Camac, MD, Lahey Clinic; Caitlin A Dionne, RN BSN MSCN, Lahey Clinic; MaryAnne Muriello, MD, Lahey Clinic; Arthur Mourtzinos, MD, Lahey Clinic
PDF
Characteristics and Utilization Of MS Patients In a Commercially Insured US Population
Debra F. Eisenberg, MS, PhD, HealthCore, Inc.; Prakash Navaratnam, Rph, MPH, PhD, DataMed Solutions LLC.; Xuehua Ke, MA, HealthCore, Inc.; Howard Friedman, PhD, DataMed Solutions LLC.; Neetu Agashivala, MS, Novartis Pharmaceuticals Corporation; Timothy L. Vollmer, MD, University of Colorado Denver
PDF
Profile of a Newly Diagnosed Person with Multiple Sclerosis
Tracy flemming Tracy, OTR/L, MSCS, MSSMC, Tanner Center for MS; Bess Martin, PT, MSCS, Tanner Center for MS; Clinton Reeves, LPC, Tanner Center for MS
PDF
Examination of "Free From Falls": An MS Society Comprehensive Fall Prevention Program
Debra I Frankel, MS OTR, National Multiple Sclerosis Society; Sara Anne Tompkins, Ph.D., Colorado State University
PDF
An exploration of the impact of bladder dysfunction experienced by people with Multiple Sclerosis
Catherine M Browne, BSc (Physiotherapy), University of Limerick; Dr. Maria Garrett, PhD, BSc (Physiotherapy), University of Limerick
PDF
Examination of JUMPSTART Program: Can Do MS's One Day Lifestyle Empowerment Program
Heidi Heltzel, CEO and President, Can Do Multiple Sclerosis; Sara Anne Thompkins, Ph.D., Madipen, LLC
PDF
A Visual Guide to Enhance Patient Understanding of Relapse Terminology
Lynda Hillman, DNP, Univ of Washington, Seattle

Lubiprostone for Multiple Sclerosis-Associated Constipation
Cynthia J Irish, RN, CCRC, MSCN, University of Rochester Medical Center; Andrew D Goodman, MD, University of Rochester Medical Center; Michael P McDermott, Ph. D., University of Rochester Medical Center; Jason Morrissette, M.A., University of Rochester Medical Center
PDF
Urinary Symptoms Assessment and Management Among Patients With MS
Kristin M Khalaf, PharmD, MS, University of Arizona; Karin Coyne, PhD, MPH, United Biosource Corporation; Denise Globe, PhD, Allergan; Edward Armstrong, PharmD, University of Arizona; Daniel Malone, RPh, PhD, University of Arizona; Jack Burks, MD, Florida International University

Effect Of BG-12 (Dimethyl Fumarate) On Quality Of Life In Patients With MS
Mariko Kita, MD, Virginia Mason Medical Center, Seattle, WA, USA; Robert J. Fox, MD, FAAN, Mellen Center for Multiple Sclerosis Treatment and Research, Cleveland Clinic; Ralf Gold, MD, Ruhr University, Bochum, Germany; Gavin Giovannoni, PhD, Blizard Institute, Barts and the London School of Medicine and Dentistry, London, UK; J. Theodore Phillips, MD PhD FAAN, Baylor Institute for Immunology Research, Dallas, TX, USA; Sujata P. Sarda, PhD, Weston, MA, USA; Jessica Kong, PhD, Weston, MA, USA; Vissia Viglietta, MD, Weston, MA, USA; Sarah I. Sheikh, MD, MRCP, MSc, Weston, MA, USA; Katherine T. Dawson, MD, Weston, MA, USA; Ludwig Kappos, MD, University Hospital, Basel Neurology, Basel, Switzerland
PDF
Intermittent Self Catheterisation - The White Elephant In The Room For People With MS
Louise Kurczycki, B.AppSci(Adv Ng), GradDip(Geront), Eastern Health

A Wellness Approach In Multiple Sclerosis Care; Integration Of a Case Study
Kimberly McGuire, PhD, ABPP, MSCS, Kessler Institute for Rehabilitation
PDF
Misoprostol For Control Of Painful Tonic Spasms
Ryan Orie, MPAS, PA-C, University of Pittsburgh Medical Center; Margie O'Leary, RN, MSN, MSCN, University of Pittsburgh Medical Center; Rebecca Rosiek, RN, BSN, University of Pittsburgh Medical Center; Victoria Young, RN, BSN, University of Pittsburgh Medical Center; Rock Heyman, MD, University of Pittsburgh Medical Center
PDF
BG-12 (Dimethyl Fumarate) Tolerability Delphi Panel
Robert J. Fox, MD, FAAN, Mellen Center for Multiple Sclerosis Treatment and Research, Cleveland Clinic; Ralf Gold, MD, Ruhr University, Bochum, Germany; Eva Havrdova, MD, PhD, First Faculty of Medicine, Charles University in Prague, Prague, Czech Republic; Michael Hutchinson, FRCP, St. Vincentís Hospital; J. Theodore Phillips, MD PhD FAAN, Baylor Institute for Immunology Research, Dallas, TX, USA
PDF
RCT Of a Behavioral Intervention Targeting Physical Activity and Symptoms In MS
Lara A Pilutti, PhD, University of Illinois at Urbana-Champaign; Deirdre Dlugonski, BS, University of Illinois at Urbana-Champaign; Rachel E Klaren, BS, University of Illinois at Urbana-Champaign; Robert W Motl, PhD, University of Illinois at Urbana-Champaign
PDF
Improved Tremor Outcomes In Natalizumab-Treated Multiple Sclerosis Patients
John R Rinker II, MD, Birmingham VA Medical Center; Amber Salter, MPH, University of Alabama at Birmingham; Amy Amara, MD, PhD, University of Alabama at Birmingham; William R Meador, MD, University of Alabama at Birmingham; Harrison C Walker, MD, University of Alabama at Birmingham; Gary Cutter, PhD, University of Alabama
PDF
Women With MS Hospitalized for UTIs, Analysis of 2009 HCUP Data
Eileen A Scheid, RN, MSN, University of Rochester School of Nursing; Joyce A Smith, MS, University of Rochester School of Nursing

Development of An Interactive Fatigue Education Resource for Persons With MS
Karen VL Turpin, PhD Student, MSc, BScN, University of Alberta; Nadine Akbar, PhD Candidate, MSc, University of Toronto; Marcia Finlayson, PhD, OTR, Queens University

Prevalence of Sleep Disturbances in the NARCOMS Registry Population
Tuula Tyry, PhD, St. Joseph's Hospital and Medical Center; Amber Salter, MPH, University of Alabama at Birmingham; Ruth Ann Marrie, MD, PhD, FRCPC, University of Manitoba
PDF
See more of: CMSC